<?xml version="1.0" encoding="UTF-8"?>
<document id="30504325">
	<sentence id="s1" text="Three subcardiac muscle tissue developments, li>PTPN11- , positive regulation of endothelial cell proliferation-</i>, and li>positive regulation of protein phosphorylation</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subcardiac muscle tissue developments, JMML in neurofibromatosis type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.">
		<entity id="s1.e1" charOffset="9-42"
			type="GO" text="cardiac muscle tissue development" ontology_id="GO_0048738"/>
		<entity id="s1.e2" charOffset="29-82"
			type="GO" text="positive regulation of endothelial cell proliferation" ontology_id="GO_0001938"/>
		<entity id="s1.e3" charOffset="96-142"
			type="GO" text="positive regulation of protein phosphorylation" ontology_id="GO_00011424"/>
		<entity id="s1.e4" charOffset="243-260"
			type="HP" text="neurofibromatosis" ontology_id="HP_0001067"/>
		<entity id="s1.e5" charOffset="339-384"
			type="GO" text="ubiquitin-dependent protein catabolic process" ontology_id="GO_0006511"/>
		<entity id="s1.e6" charOffset="408-413"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e4"
		    e2="s1.e4" pgr="false"/>
		<pair id="s1.p2" e1="s1.e3"
		    e2="s1.e4" pgr="false"/>
		<pair id="s1.p3" e1="s1.e4"
		    e2="s1.e5" pgr="false"/>
		<pair id="s1.p4" e1="s1.e1"
		    e2="s1.e4" pgr="false"/>
		<pair id="s1.p5" e1="s1.e2"
		    e2="s1.e6" pgr="true"/>
		<pair id="s1.p6" e1="s1.e3"
		    e2="s1.e10" pgr="true"/>
		<pair id="s1.p7" e1="s1.e6"
		    e2="s1.e10" pgr="true"/>
		<pair id="s1.p8" e1="s1.e7"
		    e2="s1.e10" pgr="false"/>
	</sentence>
</document>
